Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Sinobiopharma’s Flagship Product OK’d for Insurance Coverage

publication date: Feb 2, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sinobiopharma, Inc. reported its most important product, the skeletal muscle relaxant KuTai (Cisatracurium Besylate), is now covered by China’s major insurance plan, the National Basic Medical Insurance, Employment Injury Insurance and Maternity Insurance (2009 Edition). The company recently reported that KuTai accounts for 96% of its revenues. More details...

Stock Symbol: (OTCBB: SNBP)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners